UR9 fundamentals
An in-depth look to CLINUVEL PHARM LTD operating, investing, and financing activities
UR9 free cash flow for H1 24 is 12.08 M CHF. For 2023, UR9 free cash flow was 21.4 M CHF and operating cash flow was 22.01 M CHF.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
TTM